| abstract |
The invention relates to the bradykinin B1 antagonists of general formula (I), wherein A, Ar, G, Q, R1 and R4 are defined as in claim 1, to the enantiomers, diastereomers, mixtures and salts thereof, especially the physiologically acceptable salts thereof with organic or inorganic acids or bases. The inventive bradykinin B1 antagonists have valuable properties. The invention also relates to the production thereof, to the drugs comprising the pharmacologically effective compounds, to the production thereof and to their use. |